Association of serum selenium with MASLD and liver fibrosis: A cross-sectional study. by Wenying Guo, Ting Weng, Yufei Song

“…<h4>Results</h4>Through the application of linear regression models, our comprehensive data analysis revealed significant insights. …”
Get full text

Free radical processes in rat liver in experimental diabetes, malignant growth and their combination by I. A. Goroshinskaya, E. M. Frantsiyants, I. V. Kaplieva, L. A. Nemashkalova, L. K. Trepitaki, P. S. Kachesova, E. I. Surikova, V. A. Bandovkina, M. I. Morozova, I. M. Kotieva

“…To study the intensity of lipid peroxidation (LPO) and indicators of antioxidant protection in the liver of rats of different sexes with combined pathology – the growth of Guerin's carcinoma in presence of experimental type 1 diabetes mellitus.Materials and methods. …”
Get full text

Screening of flavonoid aglycons’ metabolism mediated by the human liver cytochromes P450 by Benković Goran, Bojić Mirza, Maleš Željan, Tomić Siniša

Subjects: Get full text

Beneficial Effects of Capybara Oil Supplementation on Steatosis and Liver Apoptosis in Obese Mice by Luciana Lontro Alves, Priscila Gomes Pereira, Bianca Torres Ciambarella, Miguel Porto Campos, Kíssila Rabelo, Ana Lúcia Rosa Nascimento, Raíssa Leal de Carvalho dos Santos Cunha, Cherley Borba Vieira Andrade, Alan Cesar Nunes Moraes, Andressa Bernardi, Fernanda Verdini Guimarães, Jemima Fuentes Ribeiro da Silva, Jorge José de Carvalho

“…It may be associated with several diseases, such as nonalcoholic fatty liver disease (NAFLD). Polyunsaturated fatty acids (PUFA) are lipid mediators that have anti-inflammatory characteristics and can be found in animals and plants, with capybara oil (CO) being a promising source. …”
Get full text

Liver fibrosis stage classification in stacked microvascular images based on deep learning by Daisuke Miura, Hiromi Suenaga, Rino Hiwatashi, Shingo Mabu

Subjects: Get full text

Comment on: Age Matters. What Affects the Cumulative Lifespan of a Transplanted Liver? by Paolo De Simone, MD, PhD, Quirino Lai, MD, PhD

Get full text

Pifithrin-μ sensitizes mTOR-activated liver cancer to sorafenib treatment by Jiarui Lv, Yanan Wang, Jiacheng Lv, Cuiting Zheng, Xinyu Zhang, Linyan Wan, Jiayang Zhang, Fangming Liu, Hongbing Zhang

“…Abstract TSC2, a suppressor of mTOR, is inactivated in up to 20% of HBV-associated liver cancer. This subtype of liver cancer is associated with aggressive behavior and early recurrence after hepatectomy. …”
Get full text

Effect of Freezing Methods on the Physical and Chemical Properties and Protein Oxidation of Porcine Liver by Ge ZHANG, Juan YOU, Hong YANG

Subjects: “…porcine liver…”
Get full text

Iron-regulatory liver hormone hepcidin and its place in the system of congenital immunity by O. A. Smirnov

Subjects: “…liver…”
Get full text

Transfer of dysbiotic gut microbiota has beneficial effects on host liver metabolism by Simon Nicolas, Vincent Blasco‐Baque, Audren Fournel, Jerome Gilleron, Pascale Klopp, Aurelie Waget, Franck Ceppo, Alysson Marlin, Roshan Padmanabhan, Jason S Iacovoni, François Tercé, Patrice D Cani, Jean‐François Tanti, Remy Burcelin, Claude Knauf, Mireille Cormont, Matteo Serino

“…Abstract Gut microbiota dysbiosis has been implicated in a variety of systemic disorders, notably metabolic diseases including obesity and impaired liver function, but the underlying mechanisms are uncertain. …”
Get full text

Investigating the prevalence and associated factors of elevated liver enzymes and dyslipidemia during pregnancy by Ananya Dutta Mou, Nurshad Ali

Subjects: Get full text

Non-Invasive Biomarkers and Breath Tests for Diagnosis and Monitoring of Chronic Liver Diseases by Pasawat Boon-yasidhi, Wikrom Karnsakul

Subjects: “…chronic liver disease…”
Get full text

Development of novel nucleic acid therapy aimed at directly controlling liver fibrosis by Tomohiro Umezu, Masakatsu Takanashi, Koji Fujita, Akio Ishikawa, Yuichirou Harada, Yoshinari Matsumoto, Masahiko Kuroda, Yoshiki Murakami

Subjects: Get full text

Liver Transplant From a Deceased Donor With Cystinosis: A Case Report by Raeda Taj, Kim Ng, Sanmati R. Cuddapah, Elizabeth B. Rand, Melissa Bleicher, Sandra Amaral, Maarouf A. Hoteit, Rajendar K. Reddy, Eyob Feyssa, Emma E. Furth, Kim M. Olthoff, Samir Abu‐Gazala, Matthew H. Levine, Frederick Vyas, Peter L. Abt

Subjects: Get full text

Amelioration of liver fibrosis with autologous macrophages induced by IL-34-based condition by Yuichi Igarashi, Haruka Wada, Masato Muto, Ryohei Sone, Yoshinori Hasegawa, Ken-ichiro Seino

Subjects: Get full text

Comment on “Age Matters: What Affects the Cumulative Lifespan of a Transplanted Liver?” by Miho Akabane, MD, Yuki Imaoka, MD, PhD, Toshihiro Nakayama, MD, Kazunari Sasaki, MD

Get full text

RAGE is a Potential Cause of Onset and Progression of Nonalcoholic Fatty Liver Disease by Kamyar Asadipooya, Kamran B. Lankarani, Rishi Raj, Mohammadreza Kalantarhormozi

“…AGE-RAGE interaction contributes to fat accumulation in the liver leading to inflammation, fibrosis, insulin resistance, and other complications of the fatty liver disease. …”
Get full text

The Implications of Liver Biopsy Results in Patients with Myeloproliferative Neoplasms Being Treated with Ruxolitinib by Douglas Tremblay, Juan Putra, Alexander Vogel, Adam Winters, Ronald Hoffman, Thomas D. Schiano, Maria Isabel Fiel, John O. Mascarenhas

“…Relevant histologic images of liver biopsies were reviewed by an experienced liver pathologist and reported to a multidisciplinary team including hepatology and hematology. …”
Get full text

Panhypopituitarism due to Absence of the Pituitary Stalk: A Rare Aetiology of Liver Cirrhosis by Marta Gonzalez Rozas, Lidia Hernanz Roman, Diego Gonzalez Gonzalez, José Luis Pérez-Castrillón

“…Studies have established a relationship between hypothalamic-pituitary dysfunction and the onset of liver damage, which may occasionally progress to cirrhosis. …”
Get full text

Exploring the Effects of Imidacloprid on Liver Health and the Microbiome in Rats: A Comprehensive Study by Alaa T. Qumsani

Subjects: Get full text